Citigroup’s Blonder Tongue Laboratories Inc BDR Stock Holding History

Citigroup’s Portfolio BDR Stock Details BDR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q2	–	Sell	-8,751	Closed	-$8K	–	7850
2015 Q1	$8K	Buy	+8,751	New	+$16.1K	﹤0.01%	6566

Other funds holding BDR

TCM

Tufton Capital Management Hunt Valley, Maryland $596M AUM 37.37% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

BCM

Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return

VKH

Virtu KCG Holdings New York $3.6B AUM 17.11% 1-Year Est. Return

California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

CNBT

Canandaigua National Bank & Trust Canandaigua, New York $1.19B AUM

AWW

Alan W. Weber $336M AUM 75.94% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Citigroup's BDR Position: Q2 2015 in Review

Citigroup sold out of Blonder Tongue Laboratories Inc (BDR) in Q2 2015, closing a stake of 8,751 shares — an estimated $8K sold.

Citigroup first reported a position in BDR in Q1 2015 and held it in 1 quarter. The position peaked at $8K in Q1 2015. 11 funds tracked by Wall St. Rank hold BDR as of Q2 2015.

Citigroup reported no remaining Blonder Tongue Laboratories Inc position as of Q2 2015 after selling out during the quarter.
Citigroup sold 8,751 Blonder Tongue Laboratories Inc shares in Q2 2015, an estimated $8K.
Citigroup first reported a position in Blonder Tongue Laboratories Inc in Q1 2015 and held it in 1 quarter.
Citigroup's Blonder Tongue Laboratories Inc position peaked at $8K in Q1 2015.
11 funds tracked by Wall St. Rank held Blonder Tongue Laboratories Inc as of Q2 2015.

Based on Citigroup's 13F filing for Q2 2015, filed 13 Aug 2015.